Effect of Calcitriol on the Renal Microvasculature Differentiation Disturbances Induced by AT1 Blockade During

Amanda L Deluque1, Lucas F de Almeida1, Heloísa D C Francescato1

  • 1Laboratory of Renal Physiology, Department of Physiology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.

Frontiers in Medicine
|March 3, 2020
PubMed

Insights

Early life exposure to angiotensin II receptor blockers can harm kidney development. However, calcitriol treatment can mitigate these negative effects, preserving renal structure and function into adulthood.

Area of Science:

  • Nephrology
  • Developmental Biology
  • Endocrinology

Background:

  • Fetal programming can lead to lasting renal structure and function issues.
  • Calcitriol influences nephrogenesis, including endothelial cell maintenance.
  • The renin-angiotensin system (RAS) is crucial for kidney development.

Purpose of the Study:

  • To investigate calcitriol's protective effects against losartan-induced renal changes.
  • To assess the impact of AT1 receptor blockade during lactation on adult renal differentiation.

Main Methods:

  • Rats were exposed to losartan (an AT1 receptor antagonist) during lactation.
  • Calcitriol was administered to assess its mitigating effects.
  • Renal structure, function, and microvasculature differentiation were evaluated in adulthood.

Main Results:

  • Losartan exposure caused persistent adult renal disorders, including hydronephrosis, papillary atrophy, and endothelial dysfunction.
  • Calcitriol treatment significantly mitigated these losartan-induced renal alterations.
  • AT1 blockade during lactation led to altered adult renal microvasculature differentiation, which calcitriol attenuated.

Conclusions:

  • Early life AT1 receptor blockade disrupts renal microvasculature development.
  • Calcitriol administration can protect against these developmental disruptions.
  • Calcitriol shows potential as a therapeutic agent to prevent long-term renal damage from RAS interference during development.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.2K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
828
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.4K